Clifford Chance LLP’s dedicated UK ECM team advises corporates, banks, and private capital clients on the full spectrum of equity offerings, including IPOs, rights issues, and secondary placements. With integrated US securities expertise and a strong cross-border capability, the team supports complex, high-value transactions across all sectors and listing venues in EMEA. Team head Simon Thomas had a strong 2024, advising on global ECM transactions, including Pfizer’s sale of Haleon plc shares and Zabka Group’s IPO in Warsaw. Adrian Cartwright’s eminent reputation continues to generate a high volume of work for the firm, while Christopher Roe remains active on IPOs, rights issues, and other secondary capital raisings. Johannes Juette is highly experienced in advising on transactions in APAC, and Drew Rundus continues to grow his US securities practice. James Koessler is also noted as key.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit: Branchenkenntnis
Mandantenzufriedenheit: NPS ®
Anwält*innen
Hall of Fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Simon Thomas
Weitere Kernanwält*innen
Adrian Cartwright; Christopher Roe; Johannes Juette; Drew Rundus; James Koessler; Anjaneya Das